Nov 13 (Reuters)-
Immuno Biological Laboratories Co Ltd
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
6 months ended 6 months ended Year to
Sep 30, 2025 Sep 30, 2024 Mar 31, 2026
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 485 mln 444 mln 1.03
(+9.3 pct) (+21.5 pct) (+5.7 pct)
Operating 142 mln 68 mln 240 mln
(+109.0 pct) (+411.3 pct) (+14.6 pct)
Recurring 149 mln 64 mln 240 mln
(+133.4 pct) (+109.6 pct) (+14.4 pct)
Net 141 mln 71 mln 265 mln
(+98.0 pct) (+166.2 pct) (+6.4 pct)
EPS 15.21 yen 7.68 yen 28.45 yen
Ann Div NIL 6.00 yen
-Q2 div NIL NIL
-Q4 div NIL 6.00 yen
NOTE - Immuno Biological Laboratories Co Ltd.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4570.T